20/04/2014 02:24:39 Free Membership Login

   

Accentia Biopharmaceuticals

Visual Financials
Company Name: Accentia Pharmaceuticals, Inc.
Ticker Symbol: ABPI
WWW Address: www.accentia.net
CEO: Dr. Francis E. O'Donnell, Jr., M.D.
No. of Employees: 140
Common Issue Type: CS
Business Description:A biopharmaceutical company focused on the development and commercialization of late-stage, targeted therapeutic clinical products.

 
Industry Information: DRUGS - Biotechnology [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 0.23 Unchanged 0.0 - -  0.01 0.00 -
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 12.4 54.1 0.00 -0.05 0.00 0.0 0.0 0.04 - 0.00
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close0.00$
PE Ratio - LTM0.0
Market Capitalisation12.4mil
Latest Shares Outstanding54.1mil
Earnings pS (EPS)-0.05$
Dividend pS (DPS)0.00¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee130,595$
Effective Tax Rate0.0%
Float84.0mil
Float as % of Shares Outstanding0.9%
Foreign Sales4mil
Domestic Sales14mil
Selling, General & Adm/tive (SG&A) as % of Revenue1.90%
Research & Devlopment (R&D) as % of Revenue1.30%
Gross Profit Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Assets Turnover0.0%
Return on Assets (ROA)0.0%
Return on Equity (ROE)0.0%
Return on Capital Invested (ROCI)0.0%
Current Ratio
Leverage Ratio (Assets/Equity)
Interest Cover
Total Debt/Equity (Gearing Ratio)
LT Debt/Total Capital0.0%
Working Capital pS-1.02$
Cash pS0.00$
Book-Value pS-1.79$
Tangible Book-Value pS-1.17$
Cash Flow pS-0.61$
Free Cash Flow pS-0.63$
KEY FIGURES (LTM): Price info
Price/Book Ratio-0.06
Price/Tangible Book Ratio0.00
Price/Cash Flow-0.2
Price/Free Cash Flow-0.2
P/E as % of Industry Group0.0%
P/E as % of Sector Segment0.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of Payment-
Dividend Rate0.00
Current Dividend Yield0.0
5-Y Average Dividend Yield0.0
Payout Ratio0.0
5-Y Average Payout Ratio0.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week---0.0-3116,844553,605
4 Weeks0.010.000.01-25.4-25113,1722,263,455
13 Weeks0.010.000.01-23.1-2478,9244,814,368
26 Weeks0.010.000.01-37.5-44123,79514,979,252
52 Weeks0.040.000.04-85.7-106142,84335,139,597
YTD0.010.00-85.28381,7555,722,898
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
0.000.010.010.010.010.000.00
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue0.0
Income0.0
Dividend0.0
Capital SpendingNA
R&D0.00NA18.22
Normalized Inc.0.00NA0.00
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %-19.3-21.3-27.0
Earnings %0.00.00.0
EPS %0.00.00.0
EPS $0.890.46-0.65
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio-160.62
Current Ratio0.2
Quick Ratio (Acid Test)0.1
Liquidity Ratio (Cash)0.06
Receivables Turnover3.9
Average Collection Period92
Working Capital/Equity81.5
Working Capital pS-1.34
Cash-Flow pS-1.88
Free Cash-Flow pS-1.11
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio-10.25
Financial Leverage Ratio (Assets/Equity)0.0
Debt Ratio297.0
Total Debt/Equity (Gearing Ratio)0.00
LT Debt/Equity0.00
LT Debt/Capital Invested-70.8
LT Debt/Total Liabilities20.4
Interest Cover0.0
Interest/Capital Invested-58.25
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.00
Tobin's Q Ratio0.15
Current P/E Ratio - LTM0.00
Enterprise Value (EV)/EBITDA-2.72
Enterprise Value (EV)/Free Cash Flow-0.44
Dividend Yield0.0
Price/Tangible Book Ratio - LTM0.00
Price/Book Ratio - LTM-0.06
Price/Cash Flow Ratio-0.2
Price/Free Cash Flow Ratio - LTM-0.2
Price/Sales Ratio0.00
P/E Ratio (1 month ago) - LTM0.0
P/E Ratio (26 weeks ago) - LTM0.0
P/E Ratio (52 weeks ago) - LTM0.0
5-Y High P/E Ratio0.0
5-Y Low P/E Ratio0.0
5-Y Average P/E Ratio0.0
Current P/E Ratio as % of 5-Y Average P/E
P/E as % of Industry Group0.0
P/E as % of Sector Segment0.0
Current 12 Month Normalized P/E Ratio - LTM0.0
PER SHARE FIGURES
LT Debt pS0.51
Current Liabilities pS1.67
Tangible Book Value pS - LTM-1.17
Book Value pS - LTM-1.79
Capital Invested pS-0.83
Cash pS - LTM0.00
Cash Flow pS - LTM-0.61
Free Cash Flow pS - LTM-0.63
Earnings pS (EPS)-0.05
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin-239.57
Free Cash Flow Margin 5YEAR AVG-130.38
Net Profit Margin0.0
Net Profit Margin - 5YEAR AVRG.
Equity Productivity-0.28
Return on Equity (ROE)0.0
Return on Equity (ROE) - 5YEAR AVRG.
Capital Invested Productivity-0.41
Return on Capital Invested (ROCI)168.7
Return on Capital Invested (ROCI) - 5YEAR AVRG.
Assets Productivity0.40
Return on Assets (ROA)-230.0
Return on Assets (ROA) - 5YEAR AVRG.
Gross Profit Margin0.0
Gross Profit Margin - 5YEAR AVRG.
EBITDA Margin - LTM0.0
EBIT Margin - LTM0.0
Pre-Tax Profit Margin0.0
Pre-Tax Profit Margin - 5YEAR AVRG.
Effective Tax Rate0.0
Effective Tax Rate - 5YEAR AVRG.0.2
EFFICIENCY RATIOS
Cash Conversion Cycle212
Revenue per Employee130,595
Net Income per Employee-542,935
Average Collection Period107
Receivables Turnover3.9
Day's Inventory Turnover Ratio105
Inventory Turnover3.4
Inventory/Sales8.2
Accounts Payble/Sales86.26
Assets/Revenue2.50
Net Working Capital Turnover-0.34
Fixed Assets Turnover0.92
Total Assets Turnover0.4
Revenue per $ Cash11.26
Revenue per $ Plant10.38
Revenue per $ Common Equity-0.28
Revenue per $ Capital Invested-0.41
Selling, General & Adm/tive (SG&A) as % of Revenue162.5
SG&A Expense as % of Revenue - 5YEAR AVRG.0.0
Research & Devlopment (R&D) as % of Revenue108.7
R&D Expense as % of Revenue - 5YEAR AVRG.108.7

  


NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us nasdaq abpi140420 02:24